Both in Pharmaceuticals
Soligenix vs Ensysce Biosciences
Over the past year SNGX returned −76.4% and ENSC returned −80.5%; their daily moves had a correlation of 0.05.
SNGX −76.4% ENSC −80.5%Growth of $1, one year, split-adjusted
| Metric | SNGX | ENSC |
|---|---|---|
| Price | $0.3559 | $0.4210 |
| Market cap | $7.7M | $8.2M |
| Today | −3.63% | −3.88% |
| 1 month | −2.2% | +5.3% |
| 6 months | +3.2% | +8.2% |
| Year to date | −73.4% | −54.2% |
| 1 year | −77.3% | −79.9% |
| Revenue growth (YoY) | — | −15.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.8× |
| Net cash | $9.8M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 42.0% | 95.4% |
| Short % of float | 0.8% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).